Covid: UAE to start Sinopharm vaccine production from April
Julphar signs a pact with G42 Medications Trading to produce China’s Sinopharm vaccine
The UAE will start production of the Chinese Covid-19 vaccine Sinopharm from April.
Gulf Pharmaceutical Industries, also known as Julphar, on Monday said in a statement to Abu Dhabi Securities Exchange, where it is listed, that it has signed an agreement with G42 Medications Trading LCC to produce Covid-19 vaccines from China’s Sinopharm.
The Ras Al Khaimah (RAK)-based pharmaceutical company expects to start commercial production of the vaccine in April.
On Sunday, Sheikh Abdullah bin Zayed Al Nahyan, the UAE’s Minister of Foreign Affairs and International Cooperation, and Wang Yi, China’s Foreign Minister, launched the 'Life Sciences and Vaccine Manufacturing in the UAE' --- a joint project by the UAE’s Group 42 and China’s CNBG (Sinopharm) to initiate the first Covid-19 vaccine production line in the UAE.
Prime Minister Narendra Modi urged officials to ensure seamless and... READ MORE
India's crisis highlights the need to increase investment in the... READ MORE
Measures taken by government successful in controlling spread of the ... READ MORE
Previous studies had shown it was linked to a higher likelihood of... READ MORE
UK health secretary says the decision comes after detection of over... READ MORE
The report must also include a QR code which is linked to the... READ MORE
He was unable to realise when his bladder was full and began leaking. READ MORE
The restrictions, put in place to curb the spread of Covid-19, are in ... READ MORE